64 related articles for article (PubMed ID: 2807154)
41. [Current aspects of the pathology, diagnosis and therapy of C-cell carcinoma. A symposium held in Bonn, July 1991].
Briele B; Hotze A; Raue F; Buhr HP; Biersack HJ
Nuklearmedizin; 1992 Dec; 31(6):254-7. PubMed ID: 1362811
[TBL] [Abstract][Full Text] [Related]
42. [Bleedings after surgery on the thyroid gland requiring reoperations].
Romanchishen AF; Kim IIu
Vestn Khir Im I I Grek; 2012; 171(1):31-3. PubMed ID: 22645912
[TBL] [Abstract][Full Text] [Related]
43. [The effect of the primary operation on reoperations on the thyroid gland].
Neumann J; Dvorák J; Smutný S; Pilous D
Rozhl Chir; 1998 Jul; 77(7):321-4. PubMed ID: 9729913
[TBL] [Abstract][Full Text] [Related]
44. Medullary Thyroid Carcinoma-We Should Do Better.
Gosnell JE; Duh QY
JAMA Surg; 2018 Jan; 153(1):59. PubMed ID: 28973093
[No Abstract] [Full Text] [Related]
45. The role of combined imaging in metastatic medullary thyroid carcinoma: 111In-DTPA-octreotide and 131I/123I-MIBG as predictors for radionuclide therapy.
Gao Z; Biersack HJ; Ezziddin S; Logvinski T; An R
J Cancer Res Clin Oncol; 2004 Nov; 130(11):649-56. PubMed ID: 15300425
[TBL] [Abstract][Full Text] [Related]
46. Postoperative pentagastrin-stimulated serum calcitonin concentrations in patients with medullary thyroid carcinoma: reoperations in patients with concentrations bordering the detection limit.
Meybier H; Schmidt-Gayk H; Buhr H; Raue F
Henry Ford Hosp Med J; 1989; 37(3-4):138-40. PubMed ID: 2576947
[TBL] [Abstract][Full Text] [Related]
47. Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin measurement.
Bugalho MJ; Santos JR; Sobrinho L
J Surg Oncol; 2005 Jul; 91(1):56-60. PubMed ID: 15999359
[TBL] [Abstract][Full Text] [Related]
48. Medullary thyroid carcinoma (MTC)--clinical and molecular aspects on the basis of own experience.
Pomorski L; Bartkowiak J; Pisarek H; Bartos M; Narebski J
Neoplasma; 2000; 47(5):323-6. PubMed ID: 11130252
[TBL] [Abstract][Full Text] [Related]
49. Medullary carcinoma of the thyroid. An update of diagnostic and prognostic factors.
Gautvik KM
Scand J Clin Lab Invest Suppl; 1991; 206():85-92. PubMed ID: 1947764
[TBL] [Abstract][Full Text] [Related]
50. Long-term prognosis of medullary thyroid carcinoma.
Rendl G; Manzl M; Hitzl W; Sungler P; Pirich C
Clin Endocrinol (Oxf); 2008 Sep; 69(3):497-505. PubMed ID: 18331612
[TBL] [Abstract][Full Text] [Related]
51. Diagnostic procedure before reoperation in patients with medullary thyroid carcinoma.
Raue F; Winter J; Frank-Raue K; Lorenz D; Herfarth C; Ziegler R
Horm Metab Res Suppl; 1989; 21():31-4. PubMed ID: 2807154
[TBL] [Abstract][Full Text] [Related]
52. Medullary carcinoma of the thyroid gland.
Sizemore GW
Semin Oncol; 1987 Sep; 14(3):306-14. PubMed ID: 2888195
[No Abstract] [Full Text] [Related]
53. Thyroid microcarcinoma.
Pacini F
Best Pract Res Clin Endocrinol Metab; 2012 Aug; 26(4):421-9. PubMed ID: 22863385
[TBL] [Abstract][Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
